<p>Robert “Bob” Long is the Co-Founder and CEO of Microvascular Health Solutions. He is an experienced business executive, leader and entrepreneur with a proven history in strategic planning, accountability and results-driven success. As Co-Founder and CEO of MicroVascular Health Solutions (MVHS) and CEO of GlycoCheck, LLC. Bob directs commercial operations and is committed to developing an organization that identifies medical device companies and nutritional therapies focused on reducing healthcare costs. Bob and Co-Founder Hans Vink have assembled a talented team in Microvascular Health Solutions (MVHS).</p>
<p>Dr. Hans Vink, PhD is the Co-Founder and Chief Science Officer of Microvascular Health Solutions. A biomedical researcher and a pioneer in the study of the endothelial glycocalyx, Dr. Hans Vink developed the GlycoCheck technology system that allows the clinical assessment of the glycocalyx. He is often sought out to lecture at universities and medical institutions around the world due to his expertise in the science of glycocalyx observation and his passion for sharing his extensive understanding of the vascular system. Hans earned a PhD in Physics from the University of Amsterdam in 1994, where he began his study of the glycocalyx.</p>


Hans Vink and Robert Long